Related Experiment Video

Updated: Jul 1, 2025

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

Low-cost urine tenofovir assay to triage dolutegravir resistance testing

Tyler Martinson¹, Jacinta Nwogu-Attah², Matthew Spinelli³

¹Department of Medicine, University of California San Francisco, San Francisco, CA, USA; Department of Internal Medicine, Kaiser Permanente San Francisco, San Francisco, CA, USA.

The Lancet. HIV

|March 10, 2024

Abstract

No abstract available in PubMed .

More Related Videos

Prediction of HIV-1 Coreceptor Usage Tropism by Sequence Analysis using a Genotypic Approach

Prediction of HIV-1 Coreceptor Usage Tropism by Sequence Analysis using a Genotypic Approach

Published on: December 1, 2011

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 9, 2014

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Associations between self-reported PrEP use and short and long-term pharmacologic metrics of PrEP adherence among Kenyan women.

Journal of acquired immune deficiency syndromes (1999)·2026

Same-day initiation of tenofovir alafenamide-based pre-exposure prophylaxis with drug-level feedback for transgender women in Uganda.

AIDS (London, England)·2026

Cumulative Low-Level Viraemia Is Not Associated with Endothelial Function in Black African Adults With HIV.

Journal of acquired immune deficiency syndromes (1999)·2026

Sex differences in long-acting cabotegravir trough concentrations in the SEARCH study in Kenya and Uganda.

AIDS (London, England)·2026

A snapshot of how U.S. funding cuts impacted HIV care in one county of Kenya: a qualitative case study.

Frontiers in public health·2026

Four-year outcomes from an HIV research pathway program for aspiring scientists at the University of California, San Francisco Center for AIDS Research.

Research square·2026

See all related articles